Red-light therapy panel market seen reaching $1.95 billion by 2030

The red-light therapy panel market is projected to grow from $1.11 billion in 2026 to $1.95 billion by 2030, according to The Business Research Company. Demand is being fueled by skin-disorder treatment, wellness adoption, and expanding home-use and sports-recovery applications.

Why it matters: - Red-light therapy panels are moving from a niche wellness product into a broader therapeutic category. - The market’s projected growth suggests more use in home care, clinics, sports recovery, and consumer wellness. - Rising skin-disorder cases and health-conscious spending are expanding demand for non-invasive treatment options.

What happened: - The Business Research Company released its Red-Light Therapy Panel Global Market Report 2026, covering market size, trends, and forecasts through 2035. - The report says the market rose from $0.96 billion in 2025 to $1.11 billion in 2026, a 15.5% CAGR. - The market is forecast to reach $1.95 billion by 2030, growing at a 15.2% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region خلال the forecast period. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company is offering a free sample of the report. - The full report is available online.

The details: - Red-light therapy panels emit low-level red and near-infrared light that penetrates the skin and stimulates cellular functions. - The panels are used to improve skin health, reduce inflammation, support tissue repair, manage pain, and accelerate healing. - Reported growth drivers include broader use in dermatology, pain management, wellness clinics, LED availability, and clinical validation of photobiomodulation. - Forecast growth drivers include homecare adoption, sports recovery programs, innovations in light wavelengths, higher wellness spending, and online sales growth. - The report highlights emerging trends such as home-based light therapy, multi-wavelength panels, portable and foldable designs, and wider clinical acceptance of photobiomodulation. - The report links market growth to increasing skin-disorder prevalence, including acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts and skin cancer. - Cancer Australia reported in November 2025 that melanoma ranked as the 10th leading cause of cancer death in 2023, with 1,527 fatalities, and projected 1,455 deaths in 2025. - Cancer Australia estimated the lifetime risk of dying from melanoma by age 85 at 1 in 253 overall, 1 in 181 for males and 1 in 422 for females. - The report also ties demand to rising health consciousness and interest in non-invasive, wellness-oriented treatments. - A January 2025 survey by the Agriculture and Horticulture Development Board found that in December 2024, 90% of UK consumers considered diet important to health, 86% valued fitness, 48% exercised at least three times weekly, and 64% maintained a balanced diet consistently.

Between the lines: - The market outlook reflects a shift from purely cosmetic use toward broader recovery and medical-wellness positioning. - The combination of at-home devices, portable formats, and online sales points to a more consumer-driven market. - Regulatory and clinical acceptance will likely matter more as adoption expands beyond wellness buyers.

What's next: - The report expects continued growth through 2030 as homecare and sports-recovery use cases expand. - Emerging product designs and wavelength innovations are likely to shape competition. - Updated report features include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics, and trend analysis. - Readers can contact The Business Research Company for more information via the report links and published contact details.